1
|
Jiang F, Zheng Q, Zhao Q, Qi Z, Wu D, Li W, Wu X, Han C. Magnetic propelled hydrogel microrobots for actively enhancing the efficiency of lycorine hydrochloride to suppress colorectal cancer. Front Bioeng Biotechnol 2024; 12:1361617. [PMID: 38449675 PMCID: PMC10915283 DOI: 10.3389/fbioe.2024.1361617] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/26/2023] [Accepted: 01/23/2024] [Indexed: 03/08/2024] Open
Abstract
Research and development in the field of micro/nano-robots have made significant progress in the past, especially in the field of clinical medicine, where further research may lead to many revolutionary achievements. Through the research and experiment of microrobots, a controllable drug delivery system will be realized, which will solve many problems in drug treatment. In this work, we design and study the ability of magnetic-driven hydrogel microrobots to carry Lycorine hydrochloride (LH) to inhibit colorectal cancer (CRC) cells. We have successfully designed a magnetic field driven, biocompatible drug carrying hydrogel microsphere robot with Fe3O4 particles inside, which can achieve magnetic field response, and confirmed that it can transport drug through fluorescence microscope. We have successfully demonstrated the motion mode of hydrogel microrobots driven by a rotating external magnetic field. This driving method allows the microrobots to move in a precise and controllable manner, providing tremendous potential for their use in various applications. Finally, we selected drug LH and loaded it into the hydrogel microrobot for a series of experiments. LH significantly inhibited CRC cells proliferation in a dose- and time-dependent manner. LH inhibited the proliferation, mobility of CRC cells and induced apoptosis. This delivery system can significantly improve the therapeutic effect of drugs on tumors.
Collapse
Affiliation(s)
- Fengqi Jiang
- Department of Urology, Xuzhou Clinical School of Xuzhou Medical University, Xuzhou Central Hospital, Xuzhou, Jiangsu, China
- Department of General Surgery, Heilongjiang Provincial Hospital, Harbin, China
- School of Life Sciences, Jiangsu Normal University, Xuzhou, Jiangsu, China
| | - Qiuyan Zheng
- Department of Pharmacy, The Second Affiliated Hospital of Harbin Medical University, Harbin, China
| | - Qingsong Zhao
- Postdoctoral Programme of Meteria Medica Institute of Harbin University of Commerce, Harbin, China
| | - Zijuan Qi
- Department of Pathology, Heilongjiang Provincial Hospital, Harbin, China
| | - Di Wu
- Department of General Surgery, Heilongjiang Provincial Hospital, Harbin, China
| | - Wenzhong Li
- Department of General Surgery, Heilongjiang Provincial Hospital, Harbin, China
| | - Xiaoke Wu
- Department of Urology, Xuzhou Clinical School of Xuzhou Medical University, Xuzhou Central Hospital, Xuzhou, Jiangsu, China
- Department of Obstetrics and Gynecology, First Affiliated Hospital, Heilongjiang University of Chinese Medicine, Harbin, China
| | - Conghui Han
- Department of Urology, Xuzhou Clinical School of Xuzhou Medical University, Xuzhou Central Hospital, Xuzhou, Jiangsu, China
- School of Life Sciences, Jiangsu Normal University, Xuzhou, Jiangsu, China
| |
Collapse
|
2
|
Shi S, Li C, Zhang Y, Deng C, Tan M, Pan G, Du J, Ji Y, Li Q, Liang H, Liu W, Guo L, Zhao G, Liu Y, Cui H. Lycorine hydrochloride inhibits melanoma cell proliferation, migration and invasion via down-regulating p21 Cip1/WAF1. Am J Cancer Res 2021; 11:1391-1409. [PMID: 33948364 PMCID: PMC8085853] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/14/2020] [Accepted: 01/20/2021] [Indexed: 06/12/2023] Open
Abstract
Lycorine hydrochloride (LH) is an active ingredient sourced from the medicinal herb Lycoris radiata. Previous studies have suggested that LH exerts tumor suppression activity in several human cancers. However, the anti-cancer effect of LH in melanoma and the potential molecular mechanisms still need to be further studied. p21Cip1/WAF1, unlike its traditional cyclin-dependent kinase (CDK) inhibitor role, is believed to act as an oncogene under certain cellular conditions. In this research, an increased expression of p21Cip1/WAF1 was found in human melanoma tissues and positively related to the tumor invasion depth. High level of p21Cip1/WAF1 was found to correlate with bad outcomes of melanoma patients by Kaplan-Meier survival analysis. Functional experiments demonstrated that the proliferation, migration and invasion ability of A375 and MV3 melanoma cells was powerfully inhibited by LH through inducing S phase cell cycle arrest and regulating epithelial-mesenchymal transition (EMT). In NOD/SCID mice model, LH effectively inhibited the xenograft tumor growth and lung metastasis of A375 cells. Further research revealed that LH reduced p21Cip1/WAF1 protein by accelerating its ubiquitination. Importantly, the LH-induced suppression of cell proliferation and metastasis was rescued by p21Cip1/WAF1 overexpression, both in vitro an in vivo. Taken together, LH, which suppresses the proliferation and metastasis of melanoma cells via down-regulating p21Cip1/WAF1, is expected to be developed as an effective medicine for melanoma therapy.
Collapse
Affiliation(s)
- Shaomin Shi
- Department of Dermatology, The Third Hospital of Hebei Medical UniversityShijiazhuang 050000, Hebei, China
- Department of Dermatology, The Fifth Hospital of ShijiazhuangShijiazhuang 050000, Hebei, China
- State Key Laboratory of Silkworm Genome Biology, Southwest UniversityChongqing 400715, China
- Cancer Center, Medical Research Institute, Southwest UniversityChongqing 400715, China
| | - Chongyang Li
- State Key Laboratory of Silkworm Genome Biology, Southwest UniversityChongqing 400715, China
- Cancer Center, Medical Research Institute, Southwest UniversityChongqing 400715, China
| | - Yanli Zhang
- Department of Dermatology, The Third Hospital of Hebei Medical UniversityShijiazhuang 050000, Hebei, China
| | - Chaowei Deng
- State Key Laboratory of Silkworm Genome Biology, Southwest UniversityChongqing 400715, China
- Cancer Center, Medical Research Institute, Southwest UniversityChongqing 400715, China
| | - Mengqin Tan
- State Key Laboratory of Silkworm Genome Biology, Southwest UniversityChongqing 400715, China
- Cancer Center, Medical Research Institute, Southwest UniversityChongqing 400715, China
| | - Guangzhao Pan
- State Key Laboratory of Silkworm Genome Biology, Southwest UniversityChongqing 400715, China
- Cancer Center, Medical Research Institute, Southwest UniversityChongqing 400715, China
| | - Juan Du
- Department of Dermatology, The Third Hospital of Hebei Medical UniversityShijiazhuang 050000, Hebei, China
| | - Yacong Ji
- Department of Dermatology, The Third Hospital of Hebei Medical UniversityShijiazhuang 050000, Hebei, China
| | - Qian Li
- Department of Dermatology, The Third Hospital of Hebei Medical UniversityShijiazhuang 050000, Hebei, China
| | - Hanghua Liang
- State Key Laboratory of Silkworm Genome Biology, Southwest UniversityChongqing 400715, China
- Cancer Center, Medical Research Institute, Southwest UniversityChongqing 400715, China
| | - Wei Liu
- Department of Dermatology, The Third Hospital of Hebei Medical UniversityShijiazhuang 050000, Hebei, China
| | - Leiyang Guo
- Department of Dermatology, The Third Hospital of Hebei Medical UniversityShijiazhuang 050000, Hebei, China
| | - Gaichao Zhao
- State Key Laboratory of Silkworm Genome Biology, Southwest UniversityChongqing 400715, China
- Cancer Center, Medical Research Institute, Southwest UniversityChongqing 400715, China
| | - Yaling Liu
- Department of Dermatology, The Third Hospital of Hebei Medical UniversityShijiazhuang 050000, Hebei, China
| | - Hongjuan Cui
- State Key Laboratory of Silkworm Genome Biology, Southwest UniversityChongqing 400715, China
- Cancer Center, Medical Research Institute, Southwest UniversityChongqing 400715, China
| |
Collapse
|
3
|
Li MH, Liao X, Li C, Wang TT, Sun YS, Yang K, Jiang PW, Shi ST, Zhang WX, Zhang K, Li C, Yang P. Lycorine hydrochloride induces reactive oxygen species-mediated apoptosis via the mitochondrial apoptotic pathway and the JNK signaling pathway in the oral squamous cell carcinoma HSC-3 cell line. Oncol Lett 2021; 21:236. [PMID: 33613725 PMCID: PMC7856689 DOI: 10.3892/ol.2021.12497] [Citation(s) in RCA: 6] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/23/2020] [Accepted: 11/18/2020] [Indexed: 12/14/2022] Open
Abstract
Poor drug efficacy is a prominent cause of oral squamous cell carcinoma (OSCC) treatment failure. Although increased efforts in developing OSCC therapeutic strategies have been achieved in recent decades, the 5-year survival rate of patients with OSCC remains poor and effective drugs to treat OSCC are lacking. The aim of the present study was to investigate the apoptotic effect caused by lycorine hydrochloride (LH) and to identify its mechanism in the OSCC HSC-3 cell line. The findings demonstrated that LH effectively induced HSC-3 cell apoptosis and cell cycle arrest at the G0/G1 phase, resulting in the inhibition of cell proliferation. Furthermore, it was found that LH increased reactive oxygen species (ROS) production, triggered mitochondrial membrane potential (MMP) disorder, enhanced the protein expression levels of Bax, Bim, cleaved caspase-9, caspase-3 and poly(ADP-ribose) polymerase 1 and decreased Mcl-1 expression. The protein expression levels of important members of the JNK signaling pathway, including phosphorylated (p)-JNK, p-mitogen-activated protein kinase kinase 4 and p-c-Jun, were significantly increased in LH-treated cells, accompanied by an increase in ROS. However, N-acetyl cysteine (NAC), a potent antioxidant, reversed the upregulated mRNA expression of c-Jun, as well as the enhanced ROS production, the disorder of MMP and the apoptosis of HSC-3 cells induced by LH. These results suggested that LH may induce HSC-3 cell apoptosis via the ROS-mediated mitochondrial apoptotic pathway and the JNK signaling pathway, which indicated that LH may be a potential drug candidate for anti-OSCC therapy.
Collapse
Affiliation(s)
- Min-Hui Li
- Center of Science and Research, Chengdu Medical College, Chengdu, Sichuan 610500, P.R. China.,School of Basic Medicine, Chengdu Medical College, Chengdu, Sichuan 610500, P.R. China
| | - Xin Liao
- Center of Science and Research, Chengdu Medical College, Chengdu, Sichuan 610500, P.R. China.,School of Bioscience and Technology, Chengdu Medical College, Chengdu, Sichuan 610500, P.R. China
| | - Chen Li
- School of Bioscience and Technology, Chengdu Medical College, Chengdu, Sichuan 610500, P.R. China
| | - Tian-Tian Wang
- School of Bioscience and Technology, Chengdu Medical College, Chengdu, Sichuan 610500, P.R. China
| | - Yi-Song Sun
- School of Bioscience and Technology, Chengdu Medical College, Chengdu, Sichuan 610500, P.R. China
| | - Kang Yang
- School of Basic Medicine, Chengdu Medical College, Chengdu, Sichuan 610500, P.R. China
| | - Pei-Wen Jiang
- School of Basic Medicine, Chengdu Medical College, Chengdu, Sichuan 610500, P.R. China
| | - Song-Ting Shi
- School of Laboratory Medicine, Chengdu Medical College, Chengdu, Sichuan 610500, P.R. China
| | - Wen-Xin Zhang
- School of Basic Medicine, Chengdu Medical College, Chengdu, Sichuan 610500, P.R. China
| | - Kun Zhang
- School of Bioscience and Technology, Chengdu Medical College, Chengdu, Sichuan 610500, P.R. China
| | - Chao Li
- Department of Head and Neck Surgery, Sichuan Cancer Hospital and Institute, Chengdu, Sichuan 610041, P.R. China
| | - Ping Yang
- School of Basic Medicine, Chengdu Medical College, Chengdu, Sichuan 610500, P.R. China
| |
Collapse
|